Over 10,000 results
Page 27 of 100
6-K
1728fkxmxvr84057qm
8 Jul 24
Current report (foreign)
7:15am
8-K
3bpqioilc0
8 Jul 24
Results of Operations and Financial Condition
7:15am
SC TO-C
7h9ehnp28b
8 Jul 24
Information about tender offer
7:14am
8-K
n5xu03use5 jpoi
8 Jul 24
Xeris Biopharma Announces Ceo Succession Plan
7:14am
6-K
9vm68nc 6ta
8 Jul 24
Current report (foreign)
7:13am
8-K
y84ik6zgpdtx3wktqnsg
8 Jul 24
2Q 2024 Earnings Considerations
7:07am
425
5js9dra9 ezchl
8 Jul 24
Business combination disclosure
7:04am
424B3
lrv2n
8 Jul 24
Prospectus supplement
7:04am
8-K
krgjqsvkstuc6v vqc
8 Jul 24
Adicet Bio Receives FDA Fast Track Designation for ADI-270 in Metastatic/Advanced Clear Cell Renal Cell Carcinoma
7:01am
6-K
om4fig3 zh7trr
8 Jul 24
Eupraxia Pharmaceuticals to Present at Controlled Release Society 2024
7:01am
8-K
c7qkroy669
8 Jul 24
Lexeo Therapeutics Appoints Tim Van Hauwermeiren to its Board of Directors
7:01am
8-K
zgkb6l8t
8 Jul 24
Aquaron Acquisition Corp. Announces Additional Contribution to Trust Account to Extend Period to Consummate Business Combination
7:00am
8-K
kel4qh npcyvm5z3v43
8 Jul 24
CellProthera and BioCardia Collaborate on Successful Phase II Trial of ProtheraCytes™ for the Treatment of Acute Myocardial Infarction
7:00am
8-K
bp5 8jw6yf4m6mojxk1
8 Jul 24
Other Events
7:00am
8-K
75wc5uv4lv2e8h824nc5
8 Jul 24
Results of Operations and Financial Condition
7:00am
8-K
x43jjfr2cu
8 Jul 24
Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel Disease
6:59am
SC 13E3
1o31iku2o4kd6lday3ql
8 Jul 24
Going private transaction
6:55am
D
8572l 0d3y
8 Jul 24
$1.76 mm in investment fund, sold $1.76 mm, 47 investors
6:45am
6-K
fd7hy4l7b5x88i71
8 Jul 24
Kolibri Global Energy Inc. Announces Operations and Corporate Update
6:45am
425
xi13mjuxrllo9bzad4v
8 Jul 24
Business combination disclosure
6:45am